国药一致(000028.SZ)：上半年净利润6.66亿元 同比下降10.43%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025 compared to the same period last year [1] Financial Performance - The company achieved operating revenue of 36.797 billion yuan, a year-on-year decrease of 2.62% [1] - The net profit attributable to shareholders was 666 million yuan, reflecting a year-on-year decline of 10.43% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 643 million yuan, down 9.63% year-on-year [1] - Basic earnings per share were reported at 1.20 yuan [1]